Description

LL-37 Peptide

Human Cathelicidin Antimicrobial Peptide

What Is It?

LL-37 is a naturally occurring antimicrobial peptide (AMP) derived from the human cathelicidin protein hCAP-18. It is part of the body’s innate immune system, meaning it serves as one of the first lines of defense against pathogens.

LL-37 is produced by:

• Neutrophils
• Macrophages
• Epithelial cells (skin, lungs, gut)

Unlike traditional antibiotics, LL-37 functions as a broad-spectrum immune modulator, helping the body respond to bacteria, viruses, and fungi while also supporting tissue repair.

What Does It Do?

LL-37 is studied for its role in:

• Supporting immune defense against pathogens
• Disrupting bacterial biofilms
• Enhancing wound healing and tissue repair
• Modulating inflammatory responses
• Supporting skin regeneration and barrier function

It is often explored in research related to:

• Chronic infections
• Skin conditions
• Immune dysregulation
• Injury recovery

How Does It Function in the Body?

LL-37 works through several key biological mechanisms:

1. Direct Antimicrobial Action

LL-37 can:

• Disrupt bacterial cell membranes
• Neutralize viruses and fungi
• Prevent microbial adhesion and colonization

This makes it effective against a wide range of pathogens without relying on traditional antibiotic pathways.

2. Biofilm Disruption

One of LL-37’s most important properties:

• Breaks down biofilms (protective layers bacteria form)
• Makes microbes more susceptible to immune clearance

This is critical in chronic or resistant infections.

3. Immune System Modulation

LL-37 helps regulate immune signaling:

• Balances pro-inflammatory and anti-inflammatory responses
• Activates immune cells (macrophages, neutrophils)
• Enhances chemotaxis (immune cell recruitment to injury/infection sites)

It acts more like an immune optimizer than a simple stimulant.

4. Tissue Repair & Regeneration

LL-37 supports healing through:

• Promoting angiogenesis (new blood vessel formation)
• Stimulating cell migration and proliferation
• Enhancing epithelial repair (skin, gut lining, etc.)

This links immune defense directly with recovery and regeneration.

What Do Studies Show?

Research on LL-37 demonstrates:

• Broad-spectrum antimicrobial activity against bacteria, viruses, and fungi
• Ability to disrupt biofilms, improving pathogen clearance
• Increased wound healing rates in skin and tissue models
• Regulation of inflammatory pathways, helping prevent excessive immune responses

Studies also suggest LL-37 plays a role in:

• Skin health (psoriasis, wound repair)
• Respiratory defense mechanisms
• Gut barrier integrity

⚠️ Important:

Most research is preclinical or early-stage human data, and LL-37 is not FDA-approved for medical use in the U.S.

Overall Benefits

Based on current research, LL-37 is commonly positioned to support:

• Immune defense and pathogen resistance
• Biofilm disruption and infection control
• Accelerated wound healing and tissue repair
• Balanced inflammation and immune response
• Skin and epithelial barrier health